ADP-β-S (trilithium)
ADP-β-S trilithium is the trilithium salt form of ADP-β-S. ADP-β-S trilithium is the activator for P2Y12 receptor, which upregulates levels of IL-1βand IL-6 production in microglial cells, promotes the phosphorylation and nuclear translocation of NF-κB, and enhances the activation of the NLRP3 inflammasome[1].
Product Specifications
CAS Number
73536-95-5
Product Name Alternative
Adenosine 5'- (β-thiodiphosphate) (trilithium)
UNSPSC
12352005
Hazard Statement
H302, H371
Target
NF-κB; P2Y Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/adp-β-s-trilithium.html
Purity
94.9
Solubility
H2O : 20 mg/mL (ultrasonic; warming)
Smiles
O[C@H]1[C@@H](O)[C@H](N2C=NC3=C(N=CN=C32)N)O[C@@H]1COP(OP(O[Li])(S[Li])=O)(O[Li])=O
Molecular Formula
C10H12Li3N5O9P2S
Molecular Weight
461.07
Precautions
H302, H371
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
P2Y12 Receptor
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Fibronectin (TV-1), CF647 conjugate, 0.1mg/mL
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF488A conjugate, 0.1mg/mL
CD61 / Integrin 3 / Platelet Glycoprotein IIIa (Platelet Marker) (ITGB3/2597), CF594 conjugate, 0.1mg/mL
